Area of research
Epidemiology · Cardiology and Cardiovascular Medicine
Research interest
Research focused on Hepatocellular carcinoma and Postprandial, with related work in Bedaquiline, Virology, Telaprevir. Notable publications include 'HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study', 'Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment...', and 'Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent'.
TNF-α inhibits Epstein Barr virus reactivation through the GPX4 mediated glutathione pathway
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study
Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection
Comparison of simeprevir versus telaprevir plus pegylated interferon alfa and ribavirin in patients with hepatitis C virus genotype 1 infection——a meta-analysis
Effect of nucleos(t)ide analog antiviral treatment on the pathological differentiation and prognosis of hepatitis B virus-related hepatocellular carcinoma